
Elevance Health Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 85 trades in Elevance Health Inc (NYSE: ELV) since 2022, across 17 members, worth an estimated $1.9M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 41 buys against 42 sells, a modestly sell-led skew, with Democratic members responsible for 55% of the trades and Republican members 45%. The most recent disclosure shown was filed April 2026, and Ro Khanna has filed the most ELV transactions among those shown, with 10. Other recent filers include Markwayne Mullin, Michael T. McCaul, and Lisa Mcclain. One notable disclosed move was a purchase by Gilbert Cisneros on August 5, 2025, up 43.9% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Elevance Health Inc (ELV) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Elevance Health congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | |
|---|---|---|---|---|---|---|---|
![]() Ro Khanna House | Apr 7, 2026 | Mar 30, 2026 | 8 days | SELL | $1,001 - $15,000 | +37.39% | |
![]() Ro Khanna House | Mar 9, 2026 | Feb 24, 2026 | 13 days | BUY | $15,001 - $50,000 | +20.34% | |
![]() Ro Khanna House | Mar 9, 2026 | Feb 17, 2026 | 20 days | BUY | $1,001 - $15,000 | +14.18% | |
![]() Ro Khanna House | Feb 6, 2026 | Jan 29, 2026 | 8 days | SELL | $1,001 - $15,000 | +13.46% | |
![]() Markwayne Mullin Senate | Jan 16, 2026 | Dec 29, 2025 | 18 days | BUY | $15,001 - $50,000 | +13.00% | |
![]() Ro Khanna House | Dec 8, 2025 | Nov 3, 2025 | 35 days | SELL | $1,001 - $15,000 | +26.35% | |
![]() Michael T. McCaul House | Nov 10, 2025 | Oct 27, 2025 | 14 days | SELL | $15,001 - $50,000 | +15.54% | |
![]() Ro Khanna House | Oct 3, 2025 | Sep 29, 2025 | 4 days | BUY | $1,001 - $15,000 | +23.78% | |
![]() Ro Khanna House | Oct 3, 2025 | Sep 5, 2025 | 28 days | BUY | $1,001 - $15,000 | +26.86% | |
![]() Ro Khanna House | Sep 9, 2025 | Aug 26, 2025 | 14 days | BUY | $1,001 - $15,000 | +28.33% |
Elevance Health (ELV) congressional trading FAQ
Can members of Congress legally trade Elevance Health (ELV) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Elevance Health (ELV), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.
Are congressional Elevance Health (ELV) trades public?
Yes. Every congressional trade in Elevance Health (ELV) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Elevance Health (ELV)?
Members of Congress have disclosed 85 trades in Elevance Health (ELV) worth $1.9M across 17 members, according to public STOCK Act filings.
Which members of Congress have traded Elevance Health (ELV)?
Recent and active filers of Elevance Health (ELV) disclosures include Ro Khanna, Michael T. McCaul, Lisa Mcclain. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Elevance Health (ELV) more?
Across disclosed Elevance Health (ELV) trades, 55% were by Democrats and 45% by Republicans, led by Democrats (55%).
What is the most recent congressional Elevance Health (ELV) trade?
The most recent disclosed Elevance Health (ELV) trade was a sale by Ro Khanna, filed Apr 6, 2026.
Browse all stocks Congress tradesCongressional trading overviewElevance Health (ELV) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.


